{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:01:20Z","timestamp":1790996480642,"version":"4.1.0"},"reference-count":183,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lfs.2024.123010","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:32:19Z","timestamp":1724445139000},"page":"123010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects"],"prefix":"10.1016","volume":"355","author":[{"given":"Ashutosh","family":"Pareek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjhun","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaushi","family":"Pareek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terisha","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devesh U.","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashumati","family":"Ratan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil A.","family":"Chuturgoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.123010_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/biom14010073","article-title":"Advancements in genetic and biochemical insights: unraveling the etiopathogenesis of neurodegeneration in Parkinson\u2019s disease","volume":"14","author":"Ratan","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2024.123010_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.maturitas.2015.11.009","article-title":"Brain aging and Parkinson\u2019s disease: new therapeutic approaches using drug delivery systems","volume":"84","author":"Rodr\u00edguez-Nogales","year":"2016","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","article-title":"Parkinson\u2019s disease: a multisystem disorder","volume":"39","author":"Costa","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"issue":"8","key":"10.1016\/j.lfs.2024.123010_bb0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.lfs.2024.123010_bb0035","unstructured":"World Health Organization, Parkinson disease. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/parkinson-disease (2020) (accessed 15 April 2024)."},{"issue":"4","key":"10.1016\/j.lfs.2024.123010_bb0040","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/biom11040612","article-title":"Treatment options for motor and non-motor symptoms of Parkinson\u2019s disease","volume":"11","author":"Church","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2024.123010_bb0045","first-page":"495","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders, Mol Neurobiol."},{"key":"10.1016\/j.lfs.2024.123010_bb0050","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuron.2022.01.017","article-title":"The different autophagy degradation pathways and neurodegeneration","volume":"110","author":"Fleming","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2024.123010_bb0055","doi-asserted-by":"crossref","unstructured":"L. Stefanis, E. Emmanouilidou, M. Pantazopoulou, D. Kirik, K. Vekrellis, GK. Tofaris, How is alpha-synuclein cleared from the cell? J. Neurochem. 150 (2019) 577\u2013590. doi:https:\/\/doi.org\/10.1111\/jnc.14704.","DOI":"10.1111\/jnc.14704"},{"key":"10.1016\/j.lfs.2024.123010_bb0060","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/15548627.2015.1067364","article-title":"Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease","volume":"11","author":"Gan-Or","year":"2015","journal-title":"Autophagy"},{"issue":"23","key":"10.1016\/j.lfs.2024.123010_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314997","article-title":"Neuroinflammation and autophagy in Parkinson\u2019s disease-novel perspectives","volume":"23","author":"Minchev","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.31083\/j.jin2201020","article-title":"SH-SY5Y cell line in vitro models for Parkinson disease research-old practice for new trends","volume":"22","author":"Ioghen","year":"2023","journal-title":"J. Integr. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","article-title":"Current understanding of the molecular mechanisms in Parkinson's disease: targets for potential treatments","volume":"6","author":"Maiti","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.lfs.2024.123010_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fnagi.2018.00109","article-title":"Cellular and molecular basis of neurodegeneration in Parkinson disease","volume":"10","author":"Zeng","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.lfs.2024.123010_bb0090","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2024.123010_bb0100","first-page":"770","article-title":"Current treatments and new","volume":"15","author":"Pardo-Moreno","year":"2023","journal-title":"tentative therapies for Parkinson\u2019s disease, Pharmaceutics."},{"issue":"2","key":"10.1016\/j.lfs.2024.123010_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/ane.12201","article-title":"Parkinson\u2019s disease and risk of mortality: meta-analysis and systematic review","volume":"129","author":"Xu","year":"2014","journal-title":"Acta Neurol. Scand."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2024.123010_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: a guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0115","first-page":"37","article-title":"Side effects of a dopamine agonist therapy for Parkinson\u2019s disease: a mini-review of clinical pharmacology","volume":"89","author":"Borovac","year":"2016","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.lfs.2024.123010_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.02.001","article-title":"The spectrum of \u201coff\u201d in Parkinson\u2019s disease: what have we learned over 40 years?","volume":"51","author":"Chou","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.lfs.2024.123010_bb0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1570159X14666151120123025","article-title":"Current pharmaceutical treatments and alternative therapies of Parkinson\u2019s disease","volume":"14","author":"Dong","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.lfs.2024.123010_bb0130","author":"Leyden"},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jsps.2014.04.005","article-title":"Use of an Entacapone containing drug combination and risk of death: analysis of the FDA AERS (FAERS) database","volume":"23","author":"Alshammari","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.lfs.2024.123010_bb0140","unstructured":"LiverTox: clinical and research information on drug-induced liver injury, Bethesda (MD) National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Entacapone. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548152\/."},{"issue":"6","key":"10.1016\/j.lfs.2024.123010_bb0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1755-5949.2010.00145.x","article-title":"A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson\u2019s disease","volume":"16","author":"Ferreira","year":"2010","journal-title":"CNS Neurosci.Ther."},{"issue":"8","key":"10.1016\/j.lfs.2024.123010_bb0150","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/01.wnl.0000204007.46190.54","article-title":"Selegiline slows the progression of the symptoms of Parkinson disease","volume":"66","author":"Hubsher","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2024.123010_bb0155","author":"Moore"},{"issue":"2","key":"10.1016\/j.lfs.2024.123010_bb0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.25751","article-title":"Randomized trial of safinamide add-on to levodopa in Parkinson\u2019s disease with motor fluctuations","volume":"29","author":"Borgohain","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2024.123010_bb0165","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2147\/TCRM.S139545","article-title":"Safinamide in the management of patients with Parkinson\u2019s disease not stabilized on levodopa: a review of the current clinical evidence","volume":"14","author":"Bette","year":"2018","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.lfs.2024.123010_bb0170","author":"Rewane"},{"issue":"3","key":"10.1016\/j.lfs.2024.123010_bb0175","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/14740338.2014.870152","article-title":"Drug safety evaluation of ropinirole prolonged release","volume":"13","author":"Stocchi","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.lfs.2024.123010_bb0180","author":"Singh"},{"key":"10.1016\/j.lfs.2024.123010_bb0190","author":"Ahuja"},{"issue":"12","key":"10.1016\/j.lfs.2024.123010_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015298","article-title":"Amantadine for dyskinesias in Parkinson\u2019s disease: a randomized controlled trial","volume":"5","author":"Sawada","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.123010_bb0200","author":"Chang"},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0205","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/1389200217666160709204826","article-title":"Natural products combating neurodegeneration: Parkinson\u2019s disease","volume":"18","author":"Solayman","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.lfs.2024.123010_bb0210","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4067597","article-title":"Natural compounds for the management of Parkinson\u2019s disease and attention-deficit\/hyperactivity disorder","volume":"2018","author":"Corona","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2024.123010_bb0215","doi-asserted-by":"crossref","unstructured":"Y. Heng, Q. S. Zhang., Z. Mu, J. F. Hu, Y. H. Yuan, N. H. Chen, Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting \u03b1-synuclein abnormalities in the substantia nigra, Toxicol. Lett. 243 (2016) 7\u201321. doi:10. 1016\/j.toxlet.2015.12.005.","DOI":"10.1016\/j.toxlet.2015.12.005"},{"issue":"Pt 1","key":"10.1016\/j.lfs.2024.123010_bb0220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.fct.2017.08.013","article-title":"Ginsenosides Rd and Re co-treatments improve rotenone-induced oxidative stress and mitochondrial impairment in SH-SY5Y neuroblastoma cells","volume":"109","author":"Gonz\u00e1lez-Burgos","year":"2017","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123010_bb0225","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10571-015-0230-6","article-title":"Hypericum perforatum hydroalcoholic extract mitigates motor dysfunction and is neuroprotective in intrastriatal 6-hydroxydopamine rat model of parkinson\u2019s disease","volume":"36","author":"Kiasalari","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"issue":"22","key":"10.1016\/j.lfs.2024.123010_bb0230","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.3390\/molecules25225339","article-title":"Effects of grape polyphenols on the life span and neuroinflammatory alterations related to neurodegenerative Parkinson disease-like disturbances in mice","volume":"25","author":"Tikhonova","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.lfs.2024.123010_bb0235","first-page":"182","article-title":"Zhong, Z., J. Li, H. Zhong, L. Dai, X. Tang, Effects of ginkgo biloba extract on A53T \u03b1-synuclein transgenic mouse models of Parkinson\u2019s disease, Can. J","volume":"45","author":"Kuang","year":"2018","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2024.123010_bb0240","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4103\/1673-5374.187032","article-title":"Beneficial effects of date palm fruits on neurodegenerative diseases","volume":"11","author":"Essa","year":"2016","journal-title":"Neural Regen. Res."},{"issue":"11","key":"10.1016\/j.lfs.2024.123010_bb0245","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.3390\/nu14112228","article-title":"Neuroprotective effects and therapeutic potential of the Citrus flavonoid hesperetin in neurodegenerative diseases","volume":"14","author":"Evans","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.lfs.2024.123010_bb0250","doi-asserted-by":"crossref","first-page":"750","DOI":"10.14336\/AD.2022.1022","article-title":"Neuroprotective effects of black pepper and its bioactive compounds in age-related neurological disorders","volume":"14","author":"Balakrishnan","year":"2023","journal-title":"Aging Dis."},{"issue":"6","key":"10.1016\/j.lfs.2024.123010_bb0255","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.3390\/ijms160614210","article-title":"Transcriptional factors mediating retinoic acid signals in the control of energy metabolism","volume":"16","author":"Zhang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.123010_bb0260","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3233\/JPD-212671","article-title":"Role and mechanism of vitamin a metabolism in the pathophysiology of Parkinson\u2019s disease","volume":"11","author":"Marie","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.lfs.2024.123010_bb0265","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/17425255.2020.1811232","article-title":"Retinoic acid receptor-targeted drugs in neurodegenerative disease","volume":"16","author":"Clark","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.lfs.2024.123010_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6742427","article-title":"Anti-inflammatory strategy for M2 microglial polarization using retinoic acid-loaded nanoparticles","volume":"2017","author":"Machado-Pereira","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09205063.2018.1493671","article-title":"Regulation of inflammatory response of macrophages and induction of regulatory T cells by using retinoic acid-loaded nanostructured lipid carrier","volume":"30","author":"Zai","year":"2019","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.lfs.2024.123010_bb0280","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1248\/yakushi.20-00230","article-title":"Chemical biology studies using vitamin a analogs","volume":"141","author":"Wada","year":"2021","journal-title":"Yakugaku Zasshi: J. Pharma. Soci. Japan."},{"key":"10.1016\/j.lfs.2024.123010_bb0285","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7393620","article-title":"Meeting the vitamin A requirement: the efficacy and importance of \u03b2-carotene in animal species","volume":"2016","author":"Green","year":"2016","journal-title":"Sci. World J."},{"issue":"6","key":"10.1016\/j.lfs.2024.123010_bb0290","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1471-4159.2012.07697.x","article-title":"Vitamin A deficiency impairs postnatal cognitive function via inhibition of neuronal calcium excitability in hippocampus","volume":"121","author":"Jiang","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2024.123010_bb0295","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.stemcr.2018.04.024","article-title":"Retinoic acid is required for neural stem and progenitor cell proliferation in the adult hippocampus","volume":"10","author":"Mishra","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.lfs.2024.123010_bb0300","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/ada.2019.87443","article-title":"Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments","volume":"36","author":"Zasada","year":"2019","journal-title":"Postep. Dermatol. Alergol."},{"key":"10.1016\/j.lfs.2024.123010_bb0305","series-title":"Daily Routine in Cosmetic Dermatology","first-page":"157","article-title":"Retinoids","author":"Azulay","year":"2017"},{"issue":"8","key":"10.1016\/j.lfs.2024.123010_bb0310","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/09546634.2017.1309349","article-title":"Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects","volume":"28","author":"Khalil","year":"2017","journal-title":"J. Dermatology Treat."},{"key":"10.1016\/j.lfs.2024.123010_bb0315","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.lfs.2024.123010_bb0320","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fncel.2015.00250","article-title":"Neuro- protective effect of bexarotene in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"9","author":"Riancho","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2024.123010_bb0325","doi-asserted-by":"crossref","unstructured":"M. Goncalves, J. Moehlin, E. Clarke E, J. Grist, C. Hobbs, A.M. Carr, J. Jack, M.A. Mendoza-Parra, J.P.T. Corcoran, RAR\u03b2 agonist drug (C286) demonstrates efficacy in a preclinical neuropathic pain model restoring multiple pathways via DNA repair mechanisms, iScience. 20 (2019) 554\u2013566. doi:10. 1016\/j.isci.2019.09.020.","DOI":"10.1016\/j.isci.2019.09.020"},{"key":"10.1016\/j.lfs.2024.123010_bb0330","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrn2212","article-title":"Retinoic acid in the development, regeneration and maintenance of the nervous system","volume":"8","author":"Maden","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"13","key":"10.1016\/j.lfs.2024.123010_bb0335","doi-asserted-by":"crossref","DOI":"10.1242\/dev.167502","article-title":"Retinoic acid signaling pathways","volume":"146","author":"Ghyselinck","year":"2019","journal-title":"Development"},{"issue":"20","key":"10.1016\/j.lfs.2024.123010_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012622","article-title":"The use of retinoids for the prevention and treatment of skin cancers: an updated review","volume":"23","author":"Ramchatesingh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123010_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.886244","article-title":"Impacts of vitamin A deficiency on biological rhythms: insights from the literature","volume":"9","author":"Guo","year":"2022","journal-title":"Front. Nutr."},{"issue":"5","key":"10.1016\/j.lfs.2024.123010_bb0350","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1242\/dev.065938","article-title":"Retinoic acid signalling during development","volume":"139","author":"Rhinn","year":"2012","journal-title":"Development"},{"issue":"5","key":"10.1016\/j.lfs.2024.123010_bb0355","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/jnc.12345","article-title":"Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson\u2019s disease","volume":"126","author":"Goldstein","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2024.123010_bb0360","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10571-011-9780-4","article-title":"Stress, allostatic load, catecholamines, and other neurotransmitters in neurodegenerative diseases","volume":"32","author":"Goldstein","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2024.123010_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2021.644776","article-title":"Function and regulation of ALDH1A1-positive nigrostriatal dopaminergic neurons in motor control and Parkinson\u2019s disease","volume":"15","author":"Carmichael","year":"2021","journal-title":"Front. Neural Circuits"},{"issue":"3","key":"10.1016\/j.lfs.2024.123010_bb0370","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12640-017-9843-5","article-title":"Differential alterations in metabolism and proteolysis-related proteins in human Parkinson\u2019s disease substantia nigra","volume":"33","author":"Grunblatt","year":"2017","journal-title":"Neurotox. Res."},{"issue":"14","key":"10.1016\/j.lfs.2024.123010_bb0375","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1242\/dev.02865","article-title":"Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency","volume":"134","author":"Jacobs","year":"2007","journal-title":"Development"},{"issue":"10","key":"10.1016\/j.lfs.2024.123010_bb0380","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.3390\/ijms24108614","article-title":"The crucial roles of Pitx3 in midbrain dopaminergic neuron development and Parkinson\u2019s disease-associated neurodegeneration","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.lfs.2024.123010_bb0385","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1242\/dev.071704","article-title":"Retinoic acid-dependent and -independent gene-regulatory pathways of Pitx3 in meso-diencephalic dopaminergic neurons","volume":"138","author":"Jacobs","year":"2011","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.lfs.2024.123010_bb0390","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.molmed.2012.12.003","article-title":"Parkinson's disease in the nuclear age of neuroinflammation","volume":"19","author":"Nolan","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2024.123010_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.811843","article-title":"Preventive vitamin A supplementation improves striatal function in 6-hydroxydopamine hemiparkinsonian rats","volume":"9","author":"Marie","year":"2022","journal-title":"Front. Nutr."},{"issue":"5","key":"10.1016\/j.lfs.2024.123010_bb0400","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/1567202616666191026122642","article-title":"The neurovascular unit: focus on the regulation of arterial smooth muscle cells","volume":"16","author":"Quelhas","year":"2019","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.lfs.2024.123010_bb0405","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainresbull.2022.03.011","article-title":"Effect of retinoic acid on the neurovascular unit: a review","volume":"184","author":"Pouso","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"7\u20138","key":"10.1016\/j.lfs.2024.123010_bb0410","article-title":"Retinoic acid signaling in vascular development","volume":"57","author":"Pawlikowski","year":"2019","journal-title":"Genesis"},{"issue":"3","key":"10.1016\/j.lfs.2024.123010_bb0415","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/ijms20030571","article-title":"Dual roles of astrocyte-derived factors in regulation of blood-brain barrier function after brain damage","volume":"20","author":"Michinaga","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123010_bb0420","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00401-014-1335-6","article-title":"Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis","volume":"128","author":"Mizee","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123010_bb0425","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1471-4159.2012.07715.x","article-title":"Retinoic acid mediates the expression of glutamate transporter-1 in rat astrocytes through genomic RXR action and non-genomic protein kinase C signaling pathway","volume":"121","author":"Chan","year":"2012","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0430","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0270-19.2019","article-title":"Retinoic acid is required for oligo- dendrocyte precursor cell production and differentiation in the postnatal mouse corpus callosum","volume":"7","author":"Morrison","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.lfs.2024.123010_bb0435","doi-asserted-by":"crossref","unstructured":"D. Carradori, Y. Labrak, V.E. Miron, P. Saulnier, J. Eyer, V. Preat, A. des Rieux, Retinoic acid-loaded NFL-lipid nanocapsules promote oligodendrogenesis in focal white matter lesion, Biomaterials. 230 (2020) 119653. doi:10.1016\/j. biomaterials.2019.119653.","DOI":"10.1016\/j.biomaterials.2019.119653"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2024.123010_bb0440","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.005","article-title":"Inflammatory cytokine release of astrocytes in vitro is reduced by all-trans retinoic acid","volume":"229","author":"Van Neerven","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2024.123010_bb0445","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2005.01.110","article-title":"Anti-inflammatory roles of retinoic acid in rat brain astrocytes: suppression of interferon-g-induced JAK\/STAT phosphorylation","volume":"329","author":"Choi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.123010_bb0450","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jneuroim.2005.10.004","article-title":"9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes","volume":"171","author":"Xu","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2024.123010_bb0455","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1471-4159.2009.06171.x","article-title":"Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling","volume":"110","author":"Katsuki","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2024.123010_bb0460","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneuroim.2016.10.004","article-title":"All-trans retinoic acid (ATRA) prevents lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impair- ment in aged rats","volume":"300","author":"Behairi","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2024.123010_bb0465","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.lfs.2024.123010_bb0470","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ibneur.2023.11.007","article-title":"Superoxide dismutase and neurological disorders","volume":"16","author":"Chidambaram","year":"2024","journal-title":"IBRO Neuroscience Reports"},{"issue":"7","key":"10.1016\/j.lfs.2024.123010_bb0475","first-page":"570","article-title":"Dietary antioxidants and Parkinson's disease","volume":"9","author":"Park","year":"2020","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.lfs.2024.123010_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.976799","article-title":"Therapeutic insights elaborating the potential of retinoids in Alzheimer\u2019s disease","volume":"13","author":"Behl","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123010_bb0485","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0748233709103413","article-title":"The antioxidant effects of vitamin A, C, and E on aflatoxin B1-induced oxidative stress in human lymphocytes","volume":"25","author":"Alpsoy","year":"2009","journal-title":"Toxicol. Ind. Health"},{"issue":"12","key":"10.1016\/j.lfs.2024.123010_bb0490","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/WNR.0b013e3283494359","article-title":"Cystine glutamate exchanger upregulation by retinoic acid induces neuroprotection in neural stem cells","volume":"22","author":"Crockett","year":"2011","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0495","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mds.28826","article-title":"Plasma glutathione and prodromal Parkinson\u2019s disease probability","volume":"37","author":"Charisis","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2024.123010_bb0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnagi.2020.00053","article-title":"Contra-directional expression of plasma superoxide dismutase with lipoprotein cholesterol and high-sensitivity C-reactive protein as important markers of Parkinson\u2019s disease severity","volume":"12","author":"Yang","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.lfs.2024.123010_bb0505","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ceca.2018.02.001","article-title":"Retinoic acid inhibits neuronal voltage-gated calcium channels","volume":"72","author":"De Hoog","year":"2018","journal-title":"Cell Calcium"},{"issue":"4","key":"10.1016\/j.lfs.2024.123010_bb0510","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/jmp3040021","article-title":"The roles of calcium ions in Parkinson\u2019s disease: calcium channel inhibitors as a novel agents?","volume":"3","author":"Alam","year":"2022","journal-title":"J Mol. Pathol."},{"key":"10.1016\/j.lfs.2024.123010_bb0515","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1179\/1476830511Y.0000000033","article-title":"Cellular and molecular mechanisms of antioxidants in Parkinson\u2019s disease","volume":"15","author":"Sutachan","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.lfs.2024.123010_bb0520","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/antiox12030651","article-title":"Aging hallmarks and the role of oxidative stress","volume":"12","author":"Maldonado","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.lfs.2024.123010_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2019.09.016","article-title":"Normalization of hippocampal retinoic acid level corrects age-related memory deficits in rats","volume":"85","author":"Dumetz","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.lfs.2024.123010_bb0530","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/biomedicines9101310","article-title":"Systems analysis reveals ageing-related perturbations in retinoids and sex hormones in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"9","author":"Lam","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2024.123010_bb0535","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40257-016-0185-5","article-title":"Topical retinoids: therapeutic mechanisms in the treatment of photodamaged skin","volume":"17","author":"Riahi","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.lfs.2024.123010_bb0540","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41401-020-0371-0","article-title":"Synaptic and cellular plasticity in Parkinson\u2019s disease","volume":"41","author":"Chu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.lfs.2024.123010_bb0545","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/hipo.22037","article-title":"Patterning of retinoic acid signaling and cell proliferation in the hippocampus","volume":"22","author":"Goodman","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.lfs.2024.123010_bb0550","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnbeh.2014.00020","article-title":"Vitamin A status regulates glucocorticoid availability in Wistar rats: consequences on cognitive functions and hippocampal neurogenesis?","volume":"8","author":"Bonhomme","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.lfs.2024.123010_bb0555","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/1028415X.2020.1809877","article-title":"Neuronal morphology and synaptic plasticity in the hippocampus of vitamin A deficient rats","volume":"25","author":"Dumetz","year":"2022","journal-title":"Nutr. Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2024.123010_bb0560","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0896-6273(00)00043-X","article-title":"Site-specific retinoic acid production in the brain of adult songbirds","volume":"27","author":"Denisenko-Nehrbass","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2024.123010_bb0565","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0169-328X(01)00002-X","article-title":"Molecular targets of disulfiram action on song maturation in zebra finches","volume":"87","author":"Denisenko-Nehrbass","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.lfs.2024.123010_bb0570","doi-asserted-by":"crossref","unstructured":"J. Hunt, E. J. Coulson, R. Rajnarayanan, , H. Oster, A. Videnovic, O. Rawashdeh, Sleep and circadian rhythms in Parkinson's disease and preclinical models, Mol. Neurodegener. 17(1) (2022) 2. doi:https:\/\/doi.org\/10.1186\/s13024-021-00504-w.","DOI":"10.1186\/s13024-021-00504-w"},{"key":"10.1016\/j.lfs.2024.123010_bb0575","doi-asserted-by":"crossref","unstructured":"L.M. Chahine, A.W. Amara, A. Videnovic, A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 201, Sleep Med. Rev. 35 (2017) 33\u201350. doi:https:\/\/doi.org\/10.1016\/j.smrv.2016.08.001.","DOI":"10.1016\/j.smrv.2016.08.001"},{"issue":"2","key":"10.1016\/j.lfs.2024.123010_bb0580","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/cells12020286","article-title":"Retinoic acid signalling in the pineal gland is conserved across mammalian species and its transcriptional activity is inhibited by melatonin","volume":"12","author":"Ashton","year":"2023","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.lfs.2024.123010_bb0585","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1007\/s12035-018-0964-5","article-title":"Rhythmic diurnal synthesis and signaling of retinoic acid in the rat pineal gland and its action to rapidly downregulate Erk phosphorylation","volume":"55","author":"Ashton","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123010_bb0590","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.nutres.2014.02.002","article-title":"Circadian rhythms of locomotor activity and hippocampal clock genes expression are dampened in vitamin a-deficient rats","volume":"34","author":"Navigatore-Fonzo","year":"2014","journal-title":"Nutr. Res."},{"issue":"8","key":"10.1016\/j.lfs.2024.123010_bb0595","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/hipo.22007","article-title":"Daily patterns of clock and cognition-related factors are modified in the hippocampus of vitamin A-deficient rats","volume":"22","author":"Golini","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.lfs.2024.123010_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.886244","article-title":"Impacts of vitamin A deficiency on biological rhythms: insights from the literature","volume":"9","author":"Guo","year":"2022","journal-title":"Front. Nutr."},{"issue":"3","key":"10.1016\/j.lfs.2024.123010_bb0605","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.sleep.2010.09.012","article-title":"The midpoint of sleep is associated with dietary intake and dietary behavior among young japanese women","volume":"12","author":"Sato-Mito","year":"2011","journal-title":"Sleep Med."},{"key":"10.1016\/j.lfs.2024.123010_bb0610","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ctim.2018.09.003","article-title":"Effect of crocetin on quality of sleep: a randomized, double-blind, placebo-controlled, crossover study","volume":"41","author":"Umigai","year":"2018","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.lfs.2024.123010_bb0615","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jad.2019.04.048","article-title":"Depression in adolescent girls: relationship to serum vitamins a and e, immune response to heat shock protein 27 and systemic inflammation","volume":"252","author":"Bahrami","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.lfs.2024.123010_bb0620","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.smrv.2018.01.008","article-title":"Slow-wave sleep: from the cell to the clinic","volume":"41","author":"L\u00e9ger","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.lfs.2024.123010_bb0625","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fnmol.2020.00064","article-title":"\u03b1-Synuclein negatively regulates Nurr1 expression through NF-\u03baB-related mechanism","volume":"13","author":"Jia","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0630","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-022-00544-w","article-title":"The role of NURR1 in metabolic abnormalities of Parkinson\u2019s disease. Mol","volume":"17","author":"Al-Nusaif","year":"2022","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.lfs.2024.123010_bb0635","doi-asserted-by":"crossref","first-page":"14370","DOI":"10.1523\/JNEUROSCI.1155-15.2015","article-title":"Nurr1 and retinoid X receptor ligands stimulate ret signaling in dopamine neurons and can alleviate \u03b1-synuclein disrupted gene expression","volume":"35","author":"Volakakis","year":"2015","journal-title":"J. Neurosci."},{"issue":"23","key":"10.1016\/j.lfs.2024.123010_bb0640","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.3390\/ijms21238945","article-title":"Thyroid hormone signaling in embryonic stem cells: crosstalk with the retinoic acid pathway","volume":"21","author":"Fern\u00e1ndez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2024.123010_bb0645","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/EC-17-0101","article-title":"Vitamin A, endocrine tissues and hormones: interplay and interactions","volume":"6","author":"Brossaud","year":"2017","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.lfs.2024.123010_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.968215","article-title":"The relationship between thyroid disorders and vitamin A: a narrative minireview","volume":"13","author":"Capriello","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123010_bb0655","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/218145","article-title":"The role of thyroid hormones as inductors of oxidative stress and neurodegeneration","volume":"2013","author":"Villanueva","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2024.123010_bb0660","first-page":"666","article-title":"The association between vitamin D status, vitamin D supplementation, sunlight exposure, and Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"25","author":"Zhou","year":"2019","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.lfs.2024.123010_bb0665","doi-asserted-by":"crossref","unstructured":"L.A. Lima, M.J.P. Lopes, R.O. Costa, F.A.V. Lima, K.R.T. Neves, I.B. Calou, G.M. Andrade, G.S. Viana, Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats, J. Neuroinflammation 15(1) (2018) 249 1\u201311. doi:https:\/\/doi.org\/10.1186\/s12974-018-1266-6.","DOI":"10.1186\/s12974-018-1266-6"},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0670","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00210-023-02656-6","article-title":"Does vitamin D protect or treat Parkinson\u2019s disease?","volume":"397","author":"Al-kuraishy","year":"2023","journal-title":"A narrative review, Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2024.123010_bb0675","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/ejn.13869","article-title":"A neuroscience perspective of the gut theory of Parkinson\u2019s disease","volume":"49","author":"Smith","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.lfs.2024.123010_bb0680","doi-asserted-by":"crossref","unstructured":"A. Lionnet, L. Leclair-Visonneau, M. Neunlist, S. Murayama, M. Takao, C,H, Adler, P. Derkinderen, T.G. Beach, Does Parkinson's disease start in the gut? Acta. Neuropathology 135(1) (2018) 1\u201312. doi:https:\/\/doi.org\/10.1007\/s00401-017-1777-8.","DOI":"10.1007\/s00401-017-1777-8"},{"issue":"s2","key":"10.1016\/j.lfs.2024.123010_bb0685","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.3233\/JPD-191721","article-title":"Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.lfs.2024.123010_bb0690","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26850","article-title":"Live calcium and mitochondrial imaging in the enteric nervous system of Parkinson patients and controls","volume":"6","author":"Desmet","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.lfs.2024.123010_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118688","article-title":"Maternal vitamin A deficiency impairs cholinergic and nitrergic neurons, leading to gastrointestinal dysfunction in rat offspring via RAR\u03b2","volume":"264","author":"Tan","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0700","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ydbio.2013.06.021","article-title":"Retinaldehyde dehydrogenase enzymes regulate colon enteric nervous system structure and function","volume":"381","author":"Wright-Jin","year":"2013","journal-title":"Dev. Biol."},{"key":"10.1016\/j.lfs.2024.123010_bb0705","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1098412","article-title":"Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome?","volume":"14","author":"Miri","year":"2023","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.lfs.2024.123010_bb0710","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/microorganisms10091838","article-title":"Gut bacteria and neurotransmitters","volume":"10","author":"Dicks","year":"2022","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.lfs.2024.123010_bb0715","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3390\/nu13062099","article-title":"Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders","volume":"13","author":"Chen","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0720","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","article-title":"Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.lfs.2024.123010_bb0725","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1348279","article-title":"Dysbiosis of the gut micro- biota and its effect on \u03b1-synuclein and prion protein misfolding: consequences for neurodegeneration","volume":"14","author":"Mahbub","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"17","key":"10.1016\/j.lfs.2024.123010_bb0730","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.3390\/molecules27175481","article-title":"Lipopolysaccharide-induced model of neuroinflammation: mechanisms of action, research application and future directions for its use","volume":"27","author":"Skrzypczak-Wiercioch","year":"2022","journal-title":"Molecules"},{"issue":"390","key":"10.1016\/j.lfs.2024.123010_bb0735","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4069","article-title":"The effects of micronutrient deficiencies on bacterial species from the human gut microbiota","volume":"9","author":"Hibberd","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.lfs.2024.123010_bb0740","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1535370218763760","article-title":"Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis","volume":"243","author":"Lyu","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.lfs.2024.123010_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.580780","article-title":"Vitamin A deficiency in the early-life periods alters a diversity of the colonic mucosal microbiota in rats","volume":"7","author":"Chen","year":"2020","journal-title":"Front. Nutr."},{"issue":"4","key":"10.1016\/j.lfs.2024.123010_bb0750","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41385-022-00509-8","article-title":"The role of retinoic acid in the production of immunoglobulin A","volume":"15","author":"Bos","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.lfs.2024.123010_bb0755","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2354108","article-title":"Changes in intestinal microbiota are associated with islet function in a mouse model of dietary vitamin A deficiency","volume":"2020","author":"Zhou","year":"2020","journal-title":"J. Diabetes Res."},{"issue":"390","key":"10.1016\/j.lfs.2024.123010_bb0760","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4069","article-title":"The effects of micronutrient deficiencies on bacterial species from the human gut microbiota","volume":"9","author":"Hibberd","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.lfs.2024.123010_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062617","article-title":"Immunomodulation by Bifidobacterium infantis 35624 in the murine lamina propria requires retinoic acid-dependent and independent mechanisms","volume":"8","author":"Konieczna","year":"2013","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.lfs.2024.123010_bb0770","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1073\/pnas.1616874114","article-title":"Nurr1: RXR heterodimer activation as monotherapy for Parkinson\u2019s disease","volume":"114","author":"Spathis","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2024.123010_bb0775","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2202-13-120","article-title":"Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson\u2019s disease","volume":"13","author":"Yin","year":"2012","journal-title":"BMC Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2024.123010_bb0780","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12640-013-9413-4","article-title":"9-Cis retinoic acid protects against methamphetamine induced neurotoxicity in nigrostriatal dopamine neurons","volume":"25","author":"Reiner","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.lfs.2024.123010_bb0785","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnagi.2015.00020","article-title":"Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson\u2019s disease","volume":"7","author":"Esteves","year":"2015","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.lfs.2024.123010_bb0790","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/cns.14179","article-title":"Reactive astrocytes targeting with oral vitamin A: efficient neuronal regeneration for Parkinson\u2019s disease treatment and reversal of associated liver fibrosis","volume":"29","author":"El-Mezayen","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.lfs.2024.123010_bb0795","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuint.2019.02.002","article-title":"The effects of retinol oral supplementation in 6-hydroxydopamine dopaminergic denervation model in Wistar rats","volume":"125","author":"Kunzler","year":"2019","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.lfs.2024.123010_bb0800","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3390\/nu11081896","article-title":"Nutri- tional risk factors, microbiota and Parkinson\u2019s disease: what is the current evidence?","volume":"11","author":"Boulos","year":"2019","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.lfs.2024.123010_bb0805","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/biom9070271","article-title":"Role of dietary supplements in the management of Parkinson\u2019s disease","volume":"9","author":"Ciulla","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0810","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00415-017-8639-0","article-title":"Nutritional habits, risk, and progression of Parkinson disease","volume":"265","author":"Erro","year":"2018","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123010_bb0815","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4162\/nrp.2017.11.2.114","article-title":"Association of serum carotenoid, retinol, and tocopherol concentrations with the progression of Parkinson\u2019s disease","volume":"11","author":"Kim","year":"2017","journal-title":"Nutr. Res. Pract."},{"issue":"11","key":"10.1016\/j.lfs.2024.123010_bb0820","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/mds.27120","article-title":"Dietary antioxidants and risk of Parkinson\u2019s disease in two population-based cohorts","volume":"32","author":"Yang","year":"2017","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0825","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1468-1331.2010.03088.x","article-title":"Fukuoka Kinki Parkinson's Disease Study Group, Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan","volume":"18","author":"Miyake","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"2015","key":"10.1016\/j.lfs.2024.123010_bb0830","first-page":"4028","article-title":"Scientific opinion on dietary reference values for vitamin A","volume":"13","author":"European Food Safety Authority (EFSA)","year":"2015","journal-title":"EFSA J."},{"key":"10.1016\/j.lfs.2024.123010_bb0835","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60327-325-1_1","article-title":"Quantification of endogenous retinoids","volume":"652","author":"Kane","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2024.123010_bb0840","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00702-010-0509-1","article-title":"Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson\u2019s disease","volume":"117","author":"Grunblatt","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.lfs.2024.123010_bb0845","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1172\/JCI72176","article-title":"Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation","volume":"124","author":"Liu","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.123010_bb0850","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2018.12.036","article-title":"Micro- and nanotechnology approaches to improve Parkinson\u2019s disease therapy","volume":"295","author":"Torres-Ortega","year":"2019","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0855","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11220-1","article-title":"Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma","volume":"7","author":"Johnsen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.123010_bb0860","first-page":"S51","article-title":"Nanotechnology for neurodegenerative disorders, Nanomedicine Nanotechnology","volume":"8","author":"Re","year":"2012","journal-title":"Biol. Med."},{"key":"10.1016\/j.lfs.2024.123010_bb0865","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2016.09.015","article-title":"Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys","volume":"110","author":"Garbayo","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.lfs.2024.123010_bb0870","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ejpb.2013.03.034","article-title":"In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson\u2019s disease","volume":"85","author":"Herr\u00e1n","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.lfs.2024.123010_bb0875","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s11095-013-1005-8","article-title":"Angiopep-conjugated nanoparticles for targeted long-term gene therapy of parkinson\u2019s disease","volume":"30","author":"Huang","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2024.123010_bb0880","doi-asserted-by":"crossref","unstructured":"R. Zhang, Y. Li, B. Hu, Z, Lu, J. Zhang, X. Zhang, Traceable nanoparticle delivery of small interfering RNA and retinoic acid with temporally release ability to control neural stem cell differentiation for Alzheimer's disease therapy, Adv. Mater. 28(30) (2016) 6345\u20136352. doi:https:\/\/doi.org\/10.1002\/adma.201600554.","DOI":"10.1002\/adma.201600554"},{"issue":"15","key":"10.1016\/j.lfs.2024.123010_bb0885","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1039\/C5NR09077F","article-title":"Retinoic acid-loaded polymeric nanoparticles enhance vascular regulation of neural stem cell survival and differentiation after ischaemia","volume":"8","author":"Ferreira","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.lfs.2024.123010_bb0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6742427","article-title":"Anti-inflammatory strategy for M2 microglial polarization using retinoic acid-loaded nanoparticles","volume":"6","author":"Pereira","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.lfs.2024.123010_bb0895","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1021\/nn101724r","article-title":"Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles","volume":"5","author":"Maia","year":"2011","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.lfs.2024.123010_bb0900","doi-asserted-by":"crossref","first-page":"10463","DOI":"10.1021\/nn304541h","article-title":"Polymeric nanoparticles to control the differentiation of neural stem cells in the subventricular zone of the brain","volume":"6","author":"Santos","year":"2012","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.lfs.2024.123010_bb0905","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.nano.2015.05.008","article-title":"Thermo-responsive polymeric nanoparticles for enhancing neuronal differentiation of human induced pluripotent stem cells","volume":"11","author":"Seo","year":"2015","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.lfs.2024.123010_bb0910","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s12035-021-02709-y","article-title":"Retinoid X receptor: cellular and biochemical roles of nuclear receptor with a focus on neuropathological involvement","volume":"59","author":"Sharma","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123010_bb0915","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4093\/dmj.2012.36.3.167","article-title":"Retinoid metabolism and diabetes mellitus","volume":"36","author":"Rhee","year":"2012","journal-title":"Diabetes Metab. J."},{"issue":"8","key":"10.1016\/j.lfs.2024.123010_bb0920","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/nu14081553","article-title":"Retinoic acid: sexually dimorphic, anti-insulin and concentration-dependent effects on energy","volume":"14","author":"Napoli","year":"2022","journal-title":"Nutrients"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524006003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524006003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:04:12Z","timestamp":1725840252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524006003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":183,"alternative-id":["S0024320524006003"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123010","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123010"}}